Zdrowie i gospodarka · 14/10/2015
FDA Reopens Comment Period for Prescription Drug User Fee Act Reauthorization
The Food and Drug Administration (FDA) is extending the public comment period for the Prescription Drug User Fee Act (PDUFA) reauthorization until April 29, 2016, to allow more time for public input on the reauthorization process.
Source: Federal Register — Food and Drug AdministrationOpen original release →